Amundi 10x Genomics, Inc. Transaction History

Amundi

$253 Billion
Q2 2024

A detailed history of Amundi transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Amundi holds 81 shares of TXG stock, worth $1,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 62,125 99.87%

Holding current value

$1,284

Previous $2.33 Million 99.96%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$19.45 - $37.37 $1.21 Million - $2.32 Million	-62,044 Reduced 99.87%	81 $1,000
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $715,971 - $1.08 Million	19,844 Added 46.93%	62,125 $2.33 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $257,880 - $432,430	7,514 Added 21.61%	42,281 $2.37 Million
Q3 2023 Nov 14, 2023	SELL	$40.86 - $62.98 $380,896 - $587,099	-9,322 Reduced 21.14%	34,767 $1.43 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $1.44 Million - $1.65 Million	-28,178 Reduced 38.99%	44,089 $2.46 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $1.12 Million - $1.77 Million	31,708 Added 78.18%	72,267 $4.03 Million
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $989,639 - $1.68 Million	40,559 New	40,559 $1.48 Million
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $4.64 Million - $10.4 Million	-125,694 Reduced 82.4%	26,840 $1.16 Million
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $1.83 Million - $4.79 Million	-32,839 Reduced 17.72%	152,534 $11.2 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $1.04 Million - $1.41 Million	-7,706 Reduced 3.99%	185,373 $19.4 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $161,593 - $213,275	1,110 Added 0.58%	193,079 $28.1 Million
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $25.8 Million - $38.8 Million	191,969 New	191,969 $37.6 Million

Others Institutions Holding TXG

# of Institutions

286

Shares Held

95.8M

Call Options Held

162K

Put Options Held

107K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.51B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account